Publications (60) Maria Dolores Frutos Bernal publications View referenced research data.

filter_list

2025

  1. Alterations in hepatic amino acid metabolism related to MASLD in individuals with obesity

    Journal of Physiology and Biochemistry, Vol. 81, Núm. 3, pp. 625-634

  2. ApoJ and apoL1 as novel determinants of MASH: a cross-sectional study

    Lipids in Health and Disease , Vol. 24, Núm. 1

  3. Current obesity treatment: A story about beliefs, devotion and confrontation

    Cirugia Espanola, Vol. 103, Núm. 3, pp. 153-155

  4. European recommendations from healthcare professionals and people living with obesity on safe practice for bariatric and metabolic surgery medical tourism: a modified Delphi consensus statement from EASO, IFSO-EC, and ECPO

    International Journal of Surgery, Vol. 111, Núm. 2, pp. 1711-1723

  5. Hepatic HKDC1 deletion alleviates western diet-induced MASH in mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1871, Núm. 4

  6. Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis

    JHEP Reports, Vol. 7, Núm. 1

2024

  1. A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 5, pp. 1142-1145

  2. Bariatric-Metabolic Surgery is the Most Effective Intervention in Reducing Food Addiction Symptoms: A Systematic Review and Meta-Analysis

    Obesity Surgery, Vol. 34, Núm. 9, pp. 3475-3492

  3. Combined use of composite mesh and acellular dermal matrix graft for abdominal wall repair following tumour resection

    World Journal of Surgical Oncology, Vol. 22, Núm. 1

  4. Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease

    Journal of Pathology, Vol. 264, Núm. 1, pp. 101-111

  5. Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 109, Núm. 7, pp. 1781-1792

  6. RNA expression changes driven by altered epigenetics status related to NASH etiology

    Biomedicine and Pharmacotherapy, Vol. 174

  7. The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomes

    Surgery for Obesity and Related Diseases, Vol. 20, Núm. 7, pp. 652-659

  8. Triglyceride to HDL Cholesterol Ratio for the Identification of MASLD in Obesity: A Liver Biopsy-Based Case-Control Study

    Nutrients, Vol. 16, Núm. 9

2023

  1. Bile reflux after bariatric surgery

    Cirugia Espanola, Vol. 101, pp. S63-S68

  2. Ellagic acid and its metabolites urolithins A/B ameliorate most common disease phenotypes in cellular and mouse models for lysosomal storage disorders by enhancing extracellular vesicle secretion

    Neurobiology of Disease, Vol. 182

  3. Endoscopic management of intraluminal gastric band erosion using a laser lithotripsy probe

    Revista Espanola de Enfermedades Digestivas

  4. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice

    Cellular and Molecular Life Sciences, Vol. 80, Núm. 2

  5. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

    Cell death & disease, Vol. 14, Núm. 8, pp. 514

  6. Plasma short-chain fatty acid changes after bariatric surgery in patients with severe obesity

    Surgery for Obesity and Related Diseases, Vol. 19, Núm. 7, pp. 727-734